2nd World Congress on Gastroenterology & Hepatology, London
Cost-effectiveness analysis of rifaximine for the prevention of encephalopaty relapses in France
9-10 September 2019
Robert Launois
Cost-effectiveness analysis of rifaximine for the prevention of encephalopaty relapses in France